Juvenile Huntington's disease: two case reports and a review of the literature.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
01 Oct 2020
Historique:
received: 08 05 2020
accepted: 11 08 2020
entrez: 1 10 2020
pubmed: 2 10 2020
medline: 15 5 2021
Statut: epublish

Résumé

Huntington's disease is a rare, autosomal dominant neurodegenerative disease characterized by motor, cognitive, and psychiatric symptoms. Usually, the disease symptoms first appear around the age of 40, but in 5-10% of cases, they manifest before the age of 21. This is then referred to as juvenile Huntington's disease. According to the small number of cases reported in the literature, the course of juvenile Huntington's disease significantly differs from adult onset and shows significant interpatient variability, making every case unique. Our study aims to highlight the complexity and diversity of rare juvenile Huntington's disease. We report cases of two Caucasian patients with chronic tics referred to the Huntington's Disease Competence Center of Vilnius University Hospital Santaros Klinikos with suspicion of juvenile Huntington's disease due to the appearance of chronic motor tics, and behavior problems. The diagnosis of juvenile Huntington's disease was confirmed on both clinical and genetic grounds. In both cases described, the patients developed symptoms in all three main groups: motor, cognitive, and psychiatric. However, the first patient was experiencing more severe psychiatric symptoms; in the second case, motor symptoms (rigidity, tremor) were more prominent. In both cases, apathy was one of the first symptoms and affected patients' motivation to participate in treatment actively. These two case descriptions serve as an important message for clinicians seeing patients with chronic tics and gradually worsening mood and behavior, indicating the need to investigate them for rare genetic disorders. Description of these two clinical cases of juvenile Huntington's disease provides insight into how differently it manifests and progresses in young patients and the difficulties the patients and their families face. There were different but painful ways for families to accept the diagnosis. Because the disease inevitably affects the patient's closest ones, it is crucial to also provide adequate psychological and social support to all the family members. Establishment of multidisciplinary specialist centers for Huntington's disease, as demonstrated by our experience, not only allows timely diagnosis and treatment plans but also ensures thorough disease management and care for patients and systematic support for their families.

Sections du résumé

BACKGROUND BACKGROUND
Huntington's disease is a rare, autosomal dominant neurodegenerative disease characterized by motor, cognitive, and psychiatric symptoms. Usually, the disease symptoms first appear around the age of 40, but in 5-10% of cases, they manifest before the age of 21. This is then referred to as juvenile Huntington's disease. According to the small number of cases reported in the literature, the course of juvenile Huntington's disease significantly differs from adult onset and shows significant interpatient variability, making every case unique.
CASE PRESENTATION METHODS
Our study aims to highlight the complexity and diversity of rare juvenile Huntington's disease. We report cases of two Caucasian patients with chronic tics referred to the Huntington's Disease Competence Center of Vilnius University Hospital Santaros Klinikos with suspicion of juvenile Huntington's disease due to the appearance of chronic motor tics, and behavior problems. The diagnosis of juvenile Huntington's disease was confirmed on both clinical and genetic grounds. In both cases described, the patients developed symptoms in all three main groups: motor, cognitive, and psychiatric. However, the first patient was experiencing more severe psychiatric symptoms; in the second case, motor symptoms (rigidity, tremor) were more prominent. In both cases, apathy was one of the first symptoms and affected patients' motivation to participate in treatment actively. These two case descriptions serve as an important message for clinicians seeing patients with chronic tics and gradually worsening mood and behavior, indicating the need to investigate them for rare genetic disorders.
CONCLUSIONS CONCLUSIONS
Description of these two clinical cases of juvenile Huntington's disease provides insight into how differently it manifests and progresses in young patients and the difficulties the patients and their families face. There were different but painful ways for families to accept the diagnosis. Because the disease inevitably affects the patient's closest ones, it is crucial to also provide adequate psychological and social support to all the family members. Establishment of multidisciplinary specialist centers for Huntington's disease, as demonstrated by our experience, not only allows timely diagnosis and treatment plans but also ensures thorough disease management and care for patients and systematic support for their families.

Identifiants

pubmed: 32998776
doi: 10.1186/s13256-020-02494-7
pii: 10.1186/s13256-020-02494-7
pmc: PMC7528384
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

173

Références

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1411-8
pubmed: 24828898
Clin Genet. 2014 Feb;85(2):189-93
pubmed: 23398026
Eur J Neurol. 2018 Jan;25(1):24-34
pubmed: 28817209
Arch Clin Neuropsychol. 2017 Nov 1;32(7):876-887
pubmed: 28961886
Neurodegener Dis Manag. 2017 Oct;7(5):307-315
pubmed: 29043929
Eur J Hum Genet. 2013 Oct;21(10):1042-8
pubmed: 23443023
Health Soc Care Community. 2015 Sep;23(5):569-76
pubmed: 25471490
J Child Health Care. 2007 Mar;11(1):40-52
pubmed: 17287223
J Health Psychol. 2008 Jan;13(1):5-16
pubmed: 18086713
BMC Neurol. 2017 Aug 8;17(1):152
pubmed: 28789621
Curr Psychiatry Rep. 2017 Feb;19(2):9
pubmed: 28168595
Neurodegener Dis Manag. 2013 Jun 1;3(3):
pubmed: 24416077
Handb Clin Neurol. 2017;144:3-14
pubmed: 28947123
Nat Rev Neurol. 2014 Apr;10(4):204-16
pubmed: 24614516
Handb Clin Neurol. 2017;144:31-46
pubmed: 28947124

Auteurs

Sigita Lesinskienė (S)

Clinic of Psychiatry, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M.K. Čiurlionio 21/27, LT-03101, Vilnius, Lithuania. sigita.lesinskiene@mf.vu.lt.

Darja Rojaka (D)

Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Rūta Praninskienė (R)

Clinic of Children's Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Aušra Morkūnienė (A)

Centre for Medical Genetics, Vilnius University Hospital Santaros Klinikos, Member of the European Reference Network for Rare Neurological Diseases, Vilnius, Lithuania.
Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Aušra Matulevičienė (A)

Centre for Medical Genetics, Vilnius University Hospital Santaros Klinikos, Member of the European Reference Network for Rare Neurological Diseases, Vilnius, Lithuania.
Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Algirdas Utkus (A)

Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH